Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Intermittent Fasting 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Overweight 1Obesity 1Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Diet, Healthy × Clear all
NCT01525264 2016-08-18

Breast Cancer Screening Intervention

Jonsson Comprehensive Cancer Center

Phase NA Completed
434 enrolled
Breast

Breast Neoplasms

NCT01304251 2016-01-12

Effects of Short-term Fasting on Tolerance to Chemotherapy

Leiden University Medical Center

Phase NA Completed
13 enrolled
Breast

Intermittent Fasting, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡